Novel motif:100
From FANTOM5_SSTAR
name: | motif100_GCYTNCTC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0032863 | activation of Rac GTPase activity | 8.296925e-8 |
GO:0032862 | activation of Rho GTPase activity | 9.997133e-8 |
GO:0060216 | definitive hemopoiesis | 1.526459e-7 |
GO:0014812 | muscle cell migration | 2.568649e-7 |
GO:0018277 | protein deamination | 4.036051e-7 |
GO:0060977 | coronary vasculature morphogenesis | 6.060410e-7 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 9.314494e-7 |
GO:0043586 | tongue development | 1.195738e-6 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 1.234662e-6 |
GO:0071934 | thiamine transmembrane transport | 1.378612e-6 |
GO:0033693 | neurofilament bundle assembly | 1.468194e-6 |
GO:0060215 | primitive hemopoiesis | 2.388512e-6 |
GO:0045109 | intermediate filament organization | 2.860447e-6 |
GO:0016241 | regulation of macroautophagy | 3.498727e-6 |
GO:0035023 | regulation of Rho protein signal transduction | 4.675129e-6 |
GO:0014909 | smooth muscle cell migration | 4.806595e-6 |
GO:0032902 | nerve growth factor production | 5.499771e-6 |
GO:0051546 | keratinocyte migration | 6.546410e-6 |
GO:0007422 | peripheral nervous system development | 8.714653e-6 |
GO:0043585 | nose morphogenesis | 9.023183e-6 |
GO:0046847 | filopodium assembly | 9.241085e-6 |
GO:0030224 | monocyte differentiation | 1.100784e-5 |
GO:0046578 | regulation of Ras protein signal transduction | 1.187586e-5 |
GO:0071529 | cementum mineralization | 1.233623e-5 |
GO:0043353 | enucleate erythrocyte differentiation | 1.265344e-5 |
GO:0060976 | coronary vasculature development | 1.388492e-5 |
GO:0072676 | lymphocyte migration | 1.426549e-5 |
GO:0071105 | response to interleukin-11 | 1.551061e-5 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 2.042465e-5 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 2.073913e-5 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 2.264107e-5 |
GO:0032042 | mitochondrial DNA metabolic process | 3.071890e-5 |
GO:0090183 | regulation of kidney development | 3.149945e-5 |
GO:0045110 | intermediate filament bundle assembly | 3.386358e-5 |
GO:0030035 | microspike assembly | 4.427496e-5 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 4.493942e-5 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 4.686483e-5 |
GO:0060443 | mammary gland morphogenesis | 5.250634e-5 |
GO:0008628 | induction of apoptosis by hormones | 5.592728e-5 |
GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning | 5.671412e-5 |
GO:0032012 | regulation of ARF protein signal transduction | 5.712129e-5 |
GO:0051495 | positive regulation of cytoskeleton organization | 5.910637e-5 |
GO:0070294 | renal sodium ion absorption | 5.934515e-5 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 6.523569e-5 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 6.526286e-5 |
GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process | 6.688834e-5 |
GO:0010452 | histone H3-K36 methylation | 7.554594e-5 |
GO:0031129 | inductive cell-cell signaling | 7.736739e-5 |
GO:0001575 | globoside metabolic process | 7.817089e-5 |
GO:0035752 | lysosomal lumen pH elevation | 7.817089e-5 |
GO:0000046 | autophagic vacuole fusion | 7.817089e-5 |
GO:0035441 | cell migration involved in vasculogenesis | 7.999657e-5 |
GO:0006702 | androgen biosynthetic process | 8.230253e-5 |
GO:0044340 | canonical Wnt receptor signaling pathway involved in regulation of cell proliferation | 8.580593e-5 |
GO:0060525 | prostate glandular acinus development | 9.047154e-5 |
GO:0018272 | protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine | 9.589169e-5 |
GO:0032312 | regulation of ARF GTPase activity | 9.666647e-5 |
GO:0071392 | cellular response to estradiol stimulus | 9.686144e-5 |
GO:0031017 | exocrine pancreas development | 1.046556e-4 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 1.200490e-4 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 1.270572e-4 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 1.270572e-4 |
GO:0032455 | nerve growth factor processing | 1.303535e-4 |
GO:0061143 | alveolar primary septum development | 1.344744e-4 |
GO:0007296 | vitellogenesis | 1.396197e-4 |
GO:0060426 | lung vasculature development | 1.455041e-4 |
GO:0050872 | white fat cell differentiation | 1.494568e-4 |
GO:0043587 | tongue morphogenesis | 1.530556e-4 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 1.556912e-4 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 1.593355e-4 |
GO:0030879 | mammary gland development | 1.600995e-4 |
GO:0009584 | detection of visible light | 1.617811e-4 |
GO:0002230 | positive regulation of defense response to virus by host | 1.629301e-4 |
GO:0046831 | regulation of RNA export from nucleus | 1.675596e-4 |
GO:0022011 | myelination in peripheral nervous system | 1.744304e-4 |
GO:0030834 | regulation of actin filament depolymerization | 1.793091e-4 |
GO:0014037 | Schwann cell differentiation | 1.800997e-4 |
GO:0010801 | negative regulation of peptidyl-threonine phosphorylation | 1.878955e-4 |
GO:0071243 | cellular response to arsenic-containing substance | 1.894937e-4 |
GO:0060765 | regulation of androgen receptor signaling pathway | 1.930998e-4 |
GO:0051298 | centrosome duplication | 2.063494e-4 |
GO:0003096 | renal sodium ion transport | 2.248558e-4 |
GO:0032856 | activation of Ras GTPase activity | 2.254296e-4 |
GO:0002067 | glandular epithelial cell differentiation | 2.264343e-4 |
GO:0007131 | reciprocal meiotic recombination | 2.365138e-4 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 2.508993e-4 |
GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning | 2.549768e-4 |
GO:0002031 | G-protein coupled receptor internalization | 2.588634e-4 |
GO:0060052 | neurofilament cytoskeleton organization | 2.617016e-4 |
GO:0014044 | Schwann cell development | 2.624571e-4 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.722397e-4 |
GO:0042733 | embryonic digit morphogenesis | 3.046770e-4 |
GO:0001702 | gastrulation with mouth forming second | 3.352855e-4 |
GO:0035914 | skeletal muscle cell differentiation | 3.712320e-4 |
GO:0019934 | cGMP-mediated signaling | 3.753341e-4 |
GO:2000110 | negative regulation of macrophage apoptosis | 3.758765e-4 |
GO:2000363 | positive regulation of prostaglandin-E synthase activity | 3.758765e-4 |
GO:0071608 | macrophage inflammatory protein-1 alpha production | 3.758765e-4 |
GO:0032498 | detection of muramyl dipeptide | 3.758765e-4 |
GO:0006965 | positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria | 3.758765e-4 |
GO:0032701 | negative regulation of interleukin-18 production | 3.758765e-4 |
GO:0060687 | regulation of branching involved in prostate gland morphogenesis | 3.886414e-4 |
GO:0014902 | myotube differentiation | 3.892888e-4 |
GO:0048168 | regulation of neuronal synaptic plasticity | 3.994393e-4 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 4.270242e-4 |
GO:0031334 | positive regulation of protein complex assembly | 4.296944e-4 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 4.351470e-4 |
GO:0080009 | mRNA methylation | 4.351470e-4 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 4.520158e-4 |
GO:0060711 | labyrinthine layer development | 4.670877e-4 |
GO:0043542 | endothelial cell migration | 4.705423e-4 |
GO:0071593 | lymphocyte aggregation | 4.729632e-4 |
GO:0016242 | negative regulation of macroautophagy | 4.743108e-4 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 4.846883e-4 |
GO:0070670 | response to interleukin-4 | 4.957937e-4 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 5.014958e-4 |
GO:0001812 | positive regulation of type I hypersensitivity | 5.014958e-4 |
GO:0002065 | columnar/cuboidal epithelial cell differentiation | 5.075831e-4 |
GO:0042274 | ribosomal small subunit biogenesis | 5.076928e-4 |
GO:0045824 | negative regulation of innate immune response | 5.140629e-4 |
GO:0060713 | labyrinthine layer morphogenesis | 5.183331e-4 |
GO:0001955 | blood vessel maturation | 5.542711e-4 |
GO:0008624 | induction of apoptosis by extracellular signals | 5.568986e-4 |
GO:0008089 | anterograde axon cargo transport | 5.594100e-4 |
GO:0032956 | regulation of actin cytoskeleton organization | 5.839093e-4 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 5.893853e-4 |
GO:0045061 | thymic T cell selection | 6.052256e-4 |
GO:0043084 | penile erection | 6.093629e-4 |
GO:0071635 | negative regulation of transforming growth factor beta production | 6.130906e-4 |
GO:0060674 | placenta blood vessel development | 6.171683e-4 |
GO:0003279 | cardiac septum development | 6.271784e-4 |
GO:0050764 | regulation of phagocytosis | 6.571830e-4 |
GO:0032796 | uropod organization | 6.590329e-4 |
GO:0045332 | phospholipid translocation | 6.675854e-4 |
GO:0007028 | cytoplasm organization | 6.710224e-4 |
GO:0051450 | myoblast proliferation | 6.717464e-4 |
GO:0060742 | epithelial cell differentiation involved in prostate gland development | 6.885882e-4 |
GO:0071670 | smooth muscle cell chemotaxis | 7.068424e-4 |
GO:0060981 | cell migration involved in coronary angiogenesis | 7.068424e-4 |
GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity | 7.215283e-4 |
GO:0042552 | myelination | 7.615371e-4 |
GO:0060997 | dendritic spine morphogenesis | 7.620918e-4 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 7.815496e-4 |
GO:0019067 | viral assembly, maturation, egress, and release | 7.831315e-4 |
GO:0035136 | forelimb morphogenesis | 8.019590e-4 |
GO:0061034 | olfactory bulb mitral cell layer development | 8.040388e-4 |
GO:0045163 | clustering of voltage-gated potassium channels | 8.040388e-4 |
GO:0042473 | outer ear morphogenesis | 8.272932e-4 |
GO:0060603 | mammary gland duct morphogenesis | 8.709950e-4 |
GO:0030853 | negative regulation of granulocyte differentiation | 8.743119e-4 |
GO:0050775 | positive regulation of dendrite morphogenesis | 8.828766e-4 |
GO:0001826 | inner cell mass cell differentiation | 8.847553e-4 |
GO:0006264 | mitochondrial DNA replication | 9.159818e-4 |
GO:0002698 | negative regulation of immune effector process | 9.274194e-4 |
GO:0072107 | positive regulation of ureteric bud formation | 9.374516e-4 |
GO:0071104 | response to interleukin-9 | 9.691060e-4 |
GO:0048246 | macrophage chemotaxis | 9.733131e-4 |
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 1.029175e-3 |
GO:0045200 | establishment of neuroblast polarity | 1.029175e-3 |
GO:0006898 | receptor-mediated endocytosis | 1.066056e-3 |
GO:0043244 | regulation of protein complex disassembly | 1.068465e-3 |
GO:0044330 | canonical Wnt receptor signaling pathway involved in positive regulation of wound healing | 1.105530e-3 |
GO:0044329 | canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion | 1.105530e-3 |
GO:0044328 | canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration | 1.105530e-3 |
GO:2000786 | positive regulation of autophagic vacuole assembly | 1.141398e-3 |
GO:0007098 | centrosome cycle | 1.145650e-3 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 1.165146e-3 |
GO:0043088 | regulation of Cdc42 GTPase activity | 1.178410e-3 |
GO:0070858 | negative regulation of bile acid biosynthetic process | 1.197747e-3 |
GO:0021644 | vagus nerve morphogenesis | 1.231718e-3 |
GO:0002017 | regulation of blood volume by renal aldosterone | 1.233096e-3 |
GO:0046502 | uroporphyrinogen III metabolic process | 1.245239e-3 |
GO:0048755 | branching morphogenesis of a nerve | 1.246870e-3 |
GO:0045191 | regulation of isotype switching | 1.285783e-3 |
GO:0060973 | cell migration involved in heart development | 1.312527e-3 |
GO:0042723 | thiamine-containing compound metabolic process | 1.329036e-3 |
GO:0033158 | regulation of protein import into nucleus, translocation | 1.337246e-3 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 1.367602e-3 |
GO:0060056 | mammary gland involution | 1.369548e-3 |
GO:0008064 | regulation of actin polymerization or depolymerization | 1.403296e-3 |
GO:0006797 | polyphosphate metabolic process | 1.435285e-3 |
GO:0043314 | negative regulation of neutrophil degranulation | 1.437424e-3 |
GO:0048013 | ephrin receptor signaling pathway | 1.440449e-3 |
GO:0007127 | meiosis I | 1.466346e-3 |
GO:0048808 | male genitalia morphogenesis | 1.471938e-3 |
GO:0046426 | negative regulation of JAK-STAT cascade | 1.473715e-3 |
GO:0003281 | ventricular septum development | 1.582211e-3 |
GO:0019370 | leukotriene biosynthetic process | 1.604153e-3 |
GO:0016556 | mRNA modification | 1.622617e-3 |
GO:0032275 | luteinizing hormone secretion | 1.641675e-3 |
GO:0046884 | follicle-stimulating hormone secretion | 1.641675e-3 |
GO:0018352 | protein-pyridoxal-5-phosphate linkage | 1.641675e-3 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 1.641675e-3 |
GO:0060263 | regulation of respiratory burst | 1.654571e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 1.678733e-3 |
GO:0015809 | arginine transport | 1.702837e-3 |
GO:0046732 | active induction of host immune response by virus | 1.702837e-3 |
GO:0032970 | regulation of actin filament-based process | 1.746320e-3 |
GO:0001732 | formation of translation initiation complex | 1.771531e-3 |
GO:0030827 | negative regulation of cGMP biosynthetic process | 1.785840e-3 |
GO:0035129 | post-embryonic hindlimb morphogenesis | 1.785840e-3 |
GO:0016575 | histone deacetylation | 1.810372e-3 |
GO:0051454 | intracellular pH elevation | 1.811447e-3 |
GO:0043648 | dicarboxylic acid metabolic process | 1.874065e-3 |
GO:0032780 | negative regulation of ATPase activity | 1.877481e-3 |
GO:0046340 | diacylglycerol catabolic process | 1.889590e-3 |
GO:0045649 | regulation of macrophage differentiation | 1.893423e-3 |
GO:0030836 | positive regulation of actin filament depolymerization | 1.908895e-3 |
GO:0048286 | lung alveolus development | 1.920022e-3 |
GO:0097152 | mesenchymal cell apoptosis | 1.967065e-3 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 1.967065e-3 |
GO:0060982 | coronary artery morphogenesis | 1.967065e-3 |
GO:0070489 | T cell aggregation | 1.975321e-3 |
GO:0060219 | camera-type eye photoreceptor cell differentiation | 1.994802e-3 |
GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein | 1.996026e-3 |
GO:0032497 | detection of lipopolysaccharide | 1.996026e-3 |
GO:0043583 | ear development | 1.999117e-3 |
GO:0010638 | positive regulation of organelle organization | 2.013295e-3 |
GO:0071168 | protein localization to chromatin | 2.037071e-3 |
GO:0032239 | regulation of nucleobase-containing compound transport | 2.037071e-3 |
GO:0006435 | threonyl-tRNA aminoacylation | 2.037071e-3 |
GO:0002091 | negative regulation of receptor internalization | 2.037071e-3 |
GO:0061198 | fungiform papilla formation | 2.056361e-3 |
GO:0051573 | negative regulation of histone H3-K9 methylation | 2.076671e-3 |
GO:0019344 | cysteine biosynthetic process | 2.105524e-3 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 2.105524e-3 |
GO:0060022 | hard palate development | 2.106158e-3 |
GO:0046784 | intronless viral mRNA export from host nucleus | 2.106158e-3 |
GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process | 2.135892e-3 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 2.143986e-3 |
GO:0010225 | response to UV-C | 2.202047e-3 |
GO:0001768 | establishment of T cell polarity | 2.202047e-3 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 2.221549e-3 |
GO:0048266 | behavioral response to pain | 2.271198e-3 |
GO:0051645 | Golgi localization | 2.277837e-3 |
GO:0043519 | regulation of myosin II filament organization | 2.277837e-3 |
GO:0010543 | regulation of platelet activation | 2.296890e-3 |
GO:0097035 | regulation of membrane lipid distribution | 2.343288e-3 |
GO:0060363 | cranial suture morphogenesis | 2.353920e-3 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 2.385235e-3 |
GO:0001835 | blastocyst hatching | 2.399047e-3 |
GO:0045650 | negative regulation of macrophage differentiation | 2.471015e-3 |
GO:0007386 | compartment pattern specification | 2.472257e-3 |
GO:0034109 | homotypic cell-cell adhesion | 2.493705e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 2.507916e-3 |
GO:0045059 | positive thymic T cell selection | 2.536232e-3 |
GO:0034389 | lipid particle organization | 2.572877e-3 |
GO:0031503 | protein complex localization | 2.599163e-3 |
GO:0033089 | positive regulation of T cell differentiation in thymus | 2.611337e-3 |
GO:0060364 | frontal suture morphogenesis | 2.622472e-3 |
GO:0032534 | regulation of microvillus assembly | 2.635559e-3 |
GO:0043932 | ossification involved in bone remodeling | 2.642174e-3 |
GO:0060453 | regulation of gastric acid secretion | 2.696850e-3 |
GO:0048102 | autophagic cell death | 2.771980e-3 |
GO:0032790 | ribosome disassembly | 2.785979e-3 |
GO:0006529 | asparagine biosynthetic process | 2.881498e-3 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 2.881498e-3 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 2.979471e-3 |
GO:0090086 | negative regulation of protein deubiquitination | 2.987457e-3 |
GO:0007518 | myoblast cell fate determination | 2.987457e-3 |
GO:0070814 | hydrogen sulfide biosynthetic process | 2.987457e-3 |
GO:2000053 | regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 2.989547e-3 |
GO:0035455 | response to interferon-alpha | 3.011289e-3 |
GO:0030183 | B cell differentiation | 3.028877e-3 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 3.031463e-3 |
GO:0010893 | positive regulation of steroid biosynthetic process | 3.100612e-3 |
GO:0006984 | ER-nucleus signaling pathway | 3.141311e-3 |
GO:2000162 | negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | 3.149850e-3 |
GO:2000166 | negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | 3.149850e-3 |
GO:2000168 | negative regulation of planar cell polarity pathway involved in neural tube closure | 3.149850e-3 |
GO:2000151 | negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 3.149850e-3 |
GO:2000164 | negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | 3.149850e-3 |
GO:0061310 | canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | 3.149850e-3 |
GO:2000055 | positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 3.149850e-3 |
GO:0002071 | glandular epithelial cell maturation | 3.149850e-3 |
GO:2000149 | negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | 3.149850e-3 |
GO:0043300 | regulation of leukocyte degranulation | 3.296080e-3 |
GO:0010721 | negative regulation of cell development | 3.302531e-3 |
GO:0032727 | positive regulation of interferon-alpha production | 3.316037e-3 |
GO:0000712 | resolution of meiotic recombination intermediates | 3.337463e-3 |
GO:0007341 | penetration of zona pellucida | 3.375201e-3 |
GO:0002862 | negative regulation of inflammatory response to antigenic stimulus | 3.375201e-3 |
GO:0034505 | tooth mineralization | 3.416037e-3 |
GO:0035117 | embryonic arm morphogenesis | 3.424099e-3 |
GO:0014014 | negative regulation of gliogenesis | 3.445610e-3 |
GO:0031929 | TOR signaling cascade | 3.457280e-3 |
GO:0061324 | canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation | 3.472525e-3 |
GO:0019896 | axon transport of mitochondrion | 3.522257e-3 |
GO:0090042 | tubulin deacetylation | 3.554101e-3 |
GO:0070846 | Hsp90 deacetylation | 3.554101e-3 |
GO:0060209 | estrus | 3.554101e-3 |
GO:0070407 | oxidation-dependent protein catabolic process | 3.554101e-3 |
GO:0070831 | basement membrane assembly | 3.554101e-3 |
GO:0022617 | extracellular matrix disassembly | 3.608295e-3 |
GO:0008366 | axon ensheathment | 3.627939e-3 |
GO:0007172 | signal complex assembly | 3.654286e-3 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 3.916675e-3 |
GO:0006554 | lysine catabolic process | 3.952305e-3 |
GO:0051764 | actin crosslink formation | 3.967715e-3 |
GO:0018023 | peptidyl-lysine trimethylation | 3.981178e-3 |
GO:0072215 | regulation of metanephros development | 4.025329e-3 |
GO:0051323 | metaphase | 4.232677e-3 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 4.240705e-3 |
GO:0031063 | regulation of histone deacetylation | 4.257596e-3 |
GO:0060555 | induction of necroptosis by extracellular signals | 4.287106e-3 |
GO:0071897 | DNA biosynthetic process | 4.302448e-3 |
GO:0042593 | glucose homeostasis | 4.324275e-3 |
GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 4.344819e-3 |
GO:0060021 | palate development | 4.355184e-3 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 4.381230e-3 |
GO:0032287 | peripheral nervous system myelin maintenance | 4.381230e-3 |
GO:0046006 | regulation of activated T cell proliferation | 4.431735e-3 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 4.433511e-3 |
GO:0061196 | fungiform papilla development | 4.455313e-3 |
GO:0043313 | regulation of neutrophil degranulation | 4.455313e-3 |
GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation | 4.485757e-3 |
GO:0051295 | establishment of meiotic spindle localization | 4.485757e-3 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 4.515656e-3 |
GO:0031297 | replication fork processing | 4.563968e-3 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 4.594515e-3 |
GO:0021943 | formation of radial glial scaffolds | 4.598369e-3 |
GO:0032855 | positive regulation of Rac GTPase activity | 4.763336e-3 |
GO:0000018 | regulation of DNA recombination | 4.800767e-3 |
GO:0030490 | maturation of SSU-rRNA | 4.929114e-3 |
GO:0048568 | embryonic organ development | 4.935288e-3 |
GO:0061180 | mammary gland epithelium development | 4.963017e-3 |
GO:0030098 | lymphocyte differentiation | 4.992223e-3 |
GO:0060520 | activation of prostate induction by androgen receptor signaling pathway | 5.013642e-3 |
GO:0045720 | negative regulation of integrin biosynthetic process | 5.013642e-3 |
GO:0019102 | male somatic sex determination | 5.013642e-3 |
GO:0035048 | splicing factor protein import into nucleus | 5.067088e-3 |
GO:0007569 | cell aging | 5.072031e-3 |
GO:0021874 | Wnt receptor signaling pathway involved in forebrain neuroblast division | 5.158302e-3 |
GO:0090245 | axis elongation involved in somitogenesis | 5.158302e-3 |
GO:0001808 | negative regulation of type IV hypersensitivity | 5.158302e-3 |
GO:0051152 | positive regulation of smooth muscle cell differentiation | 5.194428e-3 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 5.214010e-3 |
GO:0050902 | leukocyte adhesive activation | 5.214010e-3 |
GO:0008049 | male courtship behavior | 5.300634e-3 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 5.300634e-3 |
GO:0006781 | succinyl-CoA pathway | 5.300634e-3 |
GO:0015914 | phospholipid transport | 5.345960e-3 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 5.378196e-3 |
GO:0006939 | smooth muscle contraction | 5.438600e-3 |
GO:0050766 | positive regulation of phagocytosis | 5.453435e-3 |
GO:0014013 | regulation of gliogenesis | 5.534447e-3 |
GO:0030208 | dermatan sulfate biosynthetic process | 5.608670e-3 |
GO:0010034 | response to acetate | 5.608670e-3 |
GO:0060688 | regulation of morphogenesis of a branching structure | 5.662121e-3 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 5.704703e-3 |
GO:0030838 | positive regulation of actin filament polymerization | 5.708372e-3 |
GO:0048167 | regulation of synaptic plasticity | 5.764373e-3 |
GO:0048562 | embryonic organ morphogenesis | 5.910268e-3 |
GO:0016539 | intein-mediated protein splicing | 5.944496e-3 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.997475e-3 |
GO:0032273 | positive regulation of protein polymerization | 6.082772e-3 |
GO:0006476 | protein deacetylation | 6.098224e-3 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 6.114524e-3 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 6.249791e-3 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 6.347495e-3 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 6.437780e-3 |
GO:0030835 | negative regulation of actin filament depolymerization | 6.459693e-3 |
GO:0001921 | positive regulation of receptor recycling | 6.532723e-3 |
GO:0045104 | intermediate filament cytoskeleton organization | 6.667534e-3 |
GO:0002521 | leukocyte differentiation | 6.685253e-3 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 6.702392e-3 |
GO:0006704 | glucocorticoid biosynthetic process | 6.781444e-3 |
GO:0060596 | mammary placode formation | 6.843295e-3 |
GO:0001570 | vasculogenesis | 6.926095e-3 |
GO:0060439 | trachea morphogenesis | 6.951223e-3 |
GO:0010592 | positive regulation of lamellipodium assembly | 6.964049e-3 |
GO:0046639 | negative regulation of alpha-beta T cell differentiation | 7.005281e-3 |
GO:0043476 | pigment accumulation | 7.113071e-3 |
GO:0043482 | cellular pigment accumulation | 7.113071e-3 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 7.113071e-3 |
GO:0035601 | protein deacylation | 7.223846e-3 |
GO:0060628 | regulation of ER to Golgi vesicle-mediated transport | 7.341491e-3 |
GO:0045608 | negative regulation of auditory receptor cell differentiation | 7.362586e-3 |
GO:0071407 | cellular response to organic cyclic compound | 7.410038e-3 |
GO:0060816 | random inactivation of X chromosome | 7.460812e-3 |
GO:0060840 | artery development | 7.501974e-3 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 7.516533e-3 |
GO:0044088 | regulation of vacuole organization | 7.516533e-3 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 7.516533e-3 |
GO:0001805 | positive regulation of type III hypersensitivity | 7.516533e-3 |
GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 7.516533e-3 |
GO:0016046 | detection of fungus | 7.516533e-3 |
GO:0046415 | urate metabolic process | 7.575000e-3 |
GO:0021861 | forebrain radial glial cell differentiation | 7.579859e-3 |
GO:0045112 | integrin biosynthetic process | 7.649638e-3 |
GO:0070845 | polyubiquitinated misfolded protein transport | 7.693204e-3 |
GO:0002537 | nitric oxide production involved in inflammatory response | 7.693204e-3 |
GO:0046070 | dGTP metabolic process | 7.779680e-3 |
GO:0051293 | establishment of spindle localization | 7.811985e-3 |
GO:0048255 | mRNA stabilization | 7.811985e-3 |
GO:0046532 | regulation of photoreceptor cell differentiation | 7.823724e-3 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 7.861570e-3 |
GO:0048247 | lymphocyte chemotaxis | 7.867245e-3 |
GO:0006691 | leukotriene metabolic process | 7.936900e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 7.947844e-3 |
GO:0048561 | establishment of organ orientation | 8.030415e-3 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 8.030415e-3 |
GO:0044335 | canonical Wnt receptor signaling pathway involved in neural crest cell differentiation | 8.030415e-3 |
GO:0001807 | regulation of type IV hypersensitivity | 8.030415e-3 |
GO:0070979 | protein K11-linked ubiquitination | 8.045055e-3 |
GO:0016191 | synaptic vesicle uncoating | 8.197826e-3 |
GO:0010793 | regulation of mRNA export from nucleus | 8.197826e-3 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 8.197826e-3 |
GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 8.197826e-3 |
GO:0002149 | hypochlorous acid biosynthetic process | 8.269840e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 8.322730e-3 |
GO:0032490 | detection of molecule of bacterial origin | 8.408474e-3 |
GO:0035115 | embryonic forelimb morphogenesis | 8.486296e-3 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 8.702225e-3 |
GO:0061205 | paramesonephric duct development | 8.847935e-3 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 8.847935e-3 |
GO:0032765 | positive regulation of mast cell cytokine production | 8.847935e-3 |
GO:0051224 | negative regulation of protein transport | 8.855636e-3 |
GO:0007603 | phototransduction, visible light | 8.895246e-3 |
GO:0046902 | regulation of mitochondrial membrane permeability | 8.915686e-3 |
GO:0048012 | hepatocyte growth factor receptor signaling pathway | 9.072272e-3 |
GO:0072110 | glomerular mesangial cell proliferation | 9.079976e-3 |
GO:0032530 | regulation of microvillus organization | 9.079976e-3 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 9.079976e-3 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 9.143088e-3 |
GO:0042088 | T-helper 1 type immune response | 9.301261e-3 |
GO:0032964 | collagen biosynthetic process | 9.303569e-3 |
GO:0002883 | regulation of hypersensitivity | 9.320271e-3 |
GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development | 9.406595e-3 |
GO:0032233 | positive regulation of actin filament bundle assembly | 9.485249e-3 |
GO:0061316 | canonical Wnt receptor signaling pathway involved in heart development | 9.685734e-3 |
GO:0001569 | patterning of blood vessels | 9.759308e-3 |
GO:0045355 | negative regulation of interferon-alpha biosynthetic process | 9.768286e-3 |
GO:0050868 | negative regulation of T cell activation | 9.971920e-3 |
GO:0006353 | transcription termination, DNA-dependent | 1.004308e-2 |
GO:0032763 | regulation of mast cell cytokine production | 1.007464e-2 |
GO:0040040 | thermosensory behavior | 1.012830e-2 |
GO:0010159 | specification of organ position | 1.012830e-2 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 1.027430e-2 |
GO:0035089 | establishment of apical/basal cell polarity | 1.027430e-2 |
GO:0010572 | positive regulation of platelet activation | 1.039889e-2 |
GO:0007132 | meiotic metaphase I | 1.044158e-2 |
GO:0035640 | exploration behavior | 1.050684e-2 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 1.050997e-2 |
GO:0010912 | positive regulation of isomerase activity | 1.056733e-2 |
GO:0071353 | cellular response to interleukin-4 | 1.057641e-2 |
GO:0060463 | lung lobe morphogenesis | 1.057641e-2 |
GO:0050849 | negative regulation of calcium-mediated signaling | 1.059595e-2 |
GO:0090303 | positive regulation of wound healing | 1.060024e-2 |
GO:0021932 | hindbrain radial glia guided cell migration | 1.061862e-2 |
GO:0060996 | dendritic spine development | 1.069587e-2 |
GO:0030901 | midbrain development | 1.072464e-2 |
GO:0015893 | drug transport | 1.084431e-2 |
GO:0001890 | placenta development | 1.116499e-2 |
GO:0000019 | regulation of mitotic recombination | 1.120217e-2 |
GO:0046782 | regulation of viral transcription | 1.121331e-2 |
GO:0048570 | notochord morphogenesis | 1.126138e-2 |
GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development | 1.126138e-2 |
GO:0043534 | blood vessel endothelial cell migration | 1.133338e-2 |
GO:0050765 | negative regulation of phagocytosis | 1.138672e-2 |
GO:0046885 | regulation of hormone biosynthetic process | 1.138683e-2 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 1.152626e-2 |
GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway | 1.168112e-2 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 1.174288e-2 |
GO:0071423 | malate transmembrane transport | 1.174288e-2 |
GO:0015709 | thiosulfate transport | 1.174288e-2 |
GO:0008594 | photoreceptor cell morphogenesis | 1.174288e-2 |
GO:0060325 | face morphogenesis | 1.175288e-2 |
GO:0021936 | regulation of cerebellar granule cell precursor proliferation | 1.177686e-2 |
GO:0070483 | detection of hypoxia | 1.179736e-2 |
GO:0035461 | vitamin transmembrane transport | 1.182438e-2 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 1.182438e-2 |
GO:0060980 | cell migration involved in coronary vasculogenesis | 1.182438e-2 |
GO:0090076 | relaxation of skeletal muscle | 1.197162e-2 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 1.197162e-2 |
GO:0001309 | age-dependent telomere shortening | 1.197162e-2 |
GO:0032214 | negative regulation of telomere maintenance via semi-conservative replication | 1.197162e-2 |
GO:0045940 | positive regulation of steroid metabolic process | 1.197277e-2 |
GO:0031936 | negative regulation of chromatin silencing | 1.198772e-2 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 1.204769e-2 |
GO:0060754 | positive regulation of mast cell chemotaxis | 1.214574e-2 |
GO:0034969 | histone arginine methylation | 1.214574e-2 |
GO:0033121 | regulation of purine nucleotide catabolic process | 1.215160e-2 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 1.220058e-2 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 1.220440e-2 |
GO:0070293 | renal absorption | 1.231993e-2 |
GO:0060710 | chorio-allantoic fusion | 1.245657e-2 |
GO:0021873 | forebrain neuroblast division | 1.245657e-2 |
GO:0090311 | regulation of protein deacetylation | 1.246180e-2 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 1.246601e-2 |
GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway | 1.258105e-2 |
GO:0090184 | positive regulation of kidney development | 1.260097e-2 |
GO:0055123 | digestive system development | 1.267873e-2 |
GO:0071397 | cellular response to cholesterol | 1.283619e-2 |
GO:0010756 | positive regulation of plasminogen activation | 1.292085e-2 |
GO:0032225 | regulation of synaptic transmission, dopaminergic | 1.305560e-2 |
GO:0043508 | negative regulation of JUN kinase activity | 1.305560e-2 |
GO:0070857 | regulation of bile acid biosynthetic process | 1.312149e-2 |
GO:0021784 | postganglionic parasympathetic nervous system development | 1.312149e-2 |
GO:0035137 | hindlimb morphogenesis | 1.332125e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0016579 | protein deubiquitination | 4.074329e-10 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 8.145906e-9 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 8.628653e-9 |
GO:0070646 | protein modification by small protein removal | 1.690285e-8 |
GO:0045351 | type I interferon biosynthetic process | 2.548323e-8 |
GO:0010823 | negative regulation of mitochondrion organization | 3.019485e-8 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 7.653013e-8 |
GO:0060923 | cardiac muscle cell fate commitment | 2.237281e-7 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 2.292509e-7 |
GO:2000194 | regulation of female gonad development | 5.412456e-7 |
GO:0045869 | negative regulation of retroviral genome replication | 6.256341e-7 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 6.578311e-7 |
GO:0010897 | negative regulation of triglyceride catabolic process | 6.578311e-7 |
GO:0006110 | regulation of glycolysis | 7.648458e-7 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 1.065964e-6 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.322222e-6 |
GO:0006281 | DNA repair | 1.337128e-6 |
GO:0032606 | type I interferon production | 1.707291e-6 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 2.071189e-6 |
GO:0043973 | histone H3-K4 acetylation | 2.071189e-6 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 2.071189e-6 |
GO:2000195 | negative regulation of female gonad development | 2.162919e-6 |
GO:0035601 | protein deacylation | 2.535020e-6 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 3.272323e-6 |
GO:0010821 | regulation of mitochondrion organization | 3.806446e-6 |
GO:0016575 | histone deacetylation | 3.834752e-6 |
GO:0006476 | protein deacetylation | 4.784897e-6 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 4.789367e-6 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 4.789367e-6 |
GO:0051103 | DNA ligation involved in DNA repair | 5.604897e-6 |
GO:0009972 | cytidine deamination | 7.292511e-6 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 7.445129e-6 |
GO:0032648 | regulation of interferon-beta production | 8.121634e-6 |
GO:0045091 | regulation of retroviral genome replication | 8.371647e-6 |
GO:0002077 | acrosome matrix dispersal | 8.629743e-6 |
GO:0050689 | negative regulation of defense response to virus by host | 9.089526e-6 |
GO:0006284 | base-excision repair | 1.088324e-5 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 1.182518e-5 |
GO:0032922 | circadian regulation of gene expression | 1.250495e-5 |
GO:0010830 | regulation of myotube differentiation | 1.455897e-5 |
GO:0060837 | blood vessel endothelial cell differentiation | 1.491049e-5 |
GO:0010501 | RNA secondary structure unwinding | 1.516644e-5 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 1.631503e-5 |
GO:0090022 | regulation of neutrophil chemotaxis | 1.686879e-5 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 2.136056e-5 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.366377e-5 |
GO:0015936 | coenzyme A metabolic process | 2.675756e-5 |
GO:0006266 | DNA ligation | 3.453610e-5 |
GO:0043403 | skeletal muscle tissue regeneration | 3.521781e-5 |
GO:0035623 | renal glucose absorption | 3.538195e-5 |
GO:0035621 | ER to Golgi ceramide transport | 3.538195e-5 |
GO:0043300 | regulation of leukocyte degranulation | 4.245414e-5 |
GO:0032536 | regulation of cell projection size | 4.358902e-5 |
GO:0060932 | His-Purkinje system cell differentiation | 4.431206e-5 |
GO:0060926 | pacemaker cell development | 4.431206e-5 |
GO:0042107 | cytokine metabolic process | 4.836027e-5 |
GO:0032728 | positive regulation of interferon-beta production | 6.065715e-5 |
GO:0048002 | antigen processing and presentation of peptide antigen | 6.712011e-5 |
GO:0060674 | placenta blood vessel development | 7.138893e-5 |
GO:0006783 | heme biosynthetic process | 7.249936e-5 |
GO:0003254 | regulation of membrane depolarization | 7.261030e-5 |
GO:0009119 | ribonucleoside metabolic process | 7.406410e-5 |
GO:0006914 | autophagy | 7.501867e-5 |
GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 7.702906e-5 |
GO:0070383 | DNA cytosine deamination | 9.631958e-5 |
GO:0010529 | negative regulation of transposition | 9.631958e-5 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 9.693221e-5 |
GO:0042454 | ribonucleoside catabolic process | 9.752850e-5 |
GO:0046068 | cGMP metabolic process | 1.017607e-4 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 1.021835e-4 |
GO:0045819 | positive regulation of glycogen catabolic process | 1.022313e-4 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 1.022313e-4 |
GO:0032836 | glomerular basement membrane development | 1.030129e-4 |
GO:0006102 | isocitrate metabolic process | 1.030129e-4 |
GO:0014894 | response to denervation involved in regulation of muscle adaptation | 1.030129e-4 |
GO:0002579 | positive regulation of antigen processing and presentation | 1.041665e-4 |
GO:0016557 | peroxisome membrane biogenesis | 1.061880e-4 |
GO:0042089 | cytokine biosynthetic process | 1.068576e-4 |
GO:0032425 | positive regulation of mismatch repair | 1.162544e-4 |
GO:0060911 | cardiac cell fate commitment | 1.297484e-4 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 1.302037e-4 |
GO:0015684 | ferrous iron transport | 1.320903e-4 |
GO:0007492 | endoderm development | 1.344791e-4 |
GO:0060929 | atrioventricular node cell fate commitment | 1.387140e-4 |
GO:0060928 | atrioventricular node cell development | 1.387140e-4 |
GO:0003342 | proepicardium development | 1.387140e-4 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 1.387140e-4 |
GO:0046849 | bone remodeling | 1.433978e-4 |
GO:0048742 | regulation of skeletal muscle fiber development | 1.486480e-4 |
GO:0090209 | negative regulation of triglyceride metabolic process | 1.524897e-4 |
GO:0032094 | response to food | 1.589380e-4 |
GO:0007029 | endoplasmic reticulum organization | 1.703298e-4 |
GO:0007405 | neuroblast proliferation | 1.770291e-4 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 2.005912e-4 |
GO:0045401 | positive regulation of interleukin-3 biosynthetic process | 2.005912e-4 |
GO:0007126 | meiosis | 2.023846e-4 |
GO:0043409 | negative regulation of MAPKKK cascade | 2.048467e-4 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 2.162703e-4 |
GO:0003278 | apoptosis involved in heart morphogenesis | 2.162703e-4 |
GO:0032645 | regulation of granulocyte macrophage colony-stimulating factor production | 2.263063e-4 |
GO:0006288 | base-excision repair, DNA ligation | 2.358622e-4 |
GO:0070293 | renal absorption | 2.371456e-4 |
GO:0060371 | regulation of atrial cardiomyocyte membrane depolarization | 2.469214e-4 |
GO:2000142 | regulation of transcription initiation, DNA-dependent | 2.524622e-4 |
GO:0046135 | pyrimidine nucleoside catabolic process | 2.556029e-4 |
GO:0032835 | glomerulus development | 2.614226e-4 |
GO:0090310 | negative regulation of methylation-dependent chromatin silencing | 2.650403e-4 |
GO:0031327 | negative regulation of cellular biosynthetic process | 2.652110e-4 |
GO:0009948 | anterior/posterior axis specification | 2.893101e-4 |
GO:0072015 | glomerular visceral epithelial cell development | 2.926368e-4 |
GO:0031129 | inductive cell-cell signaling | 2.999809e-4 |
GO:0051321 | meiotic cell cycle | 3.248927e-4 |
GO:0043304 | regulation of mast cell degranulation | 3.407555e-4 |
GO:0060920 | pacemaker cell differentiation | 3.492044e-4 |
GO:0045338 | farnesyl diphosphate metabolic process | 3.499627e-4 |
GO:0010906 | regulation of glucose metabolic process | 3.565747e-4 |
GO:0031133 | regulation of axon diameter | 3.587859e-4 |
GO:0061014 | positive regulation of mRNA catabolic process | 3.617076e-4 |
GO:0007252 | I-kappaB phosphorylation | 3.617076e-4 |
GO:0006750 | glutathione biosynthetic process | 3.650353e-4 |
GO:0032479 | regulation of type I interferon production | 3.733437e-4 |
GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 3.765954e-4 |
GO:0030002 | cellular anion homeostasis | 3.841311e-4 |
GO:0034349 | glial cell apoptosis | 3.856006e-4 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 3.905823e-4 |
GO:0006342 | chromatin silencing | 3.933515e-4 |
GO:0033006 | regulation of mast cell activation involved in immune response | 4.085309e-4 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.223323e-4 |
GO:0046128 | purine ribonucleoside metabolic process | 4.332313e-4 |
GO:0070634 | transepithelial ammonium transport | 4.354888e-4 |
GO:0045368 | positive regulation of interleukin-13 biosynthetic process | 4.354888e-4 |
GO:0042168 | heme metabolic process | 4.388879e-4 |
GO:0035518 | histone H2A monoubiquitination | 4.553156e-4 |
GO:0003166 | bundle of His development | 4.602395e-4 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 4.613996e-4 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 4.613996e-4 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 4.613996e-4 |
GO:0032707 | negative regulation of interleukin-23 production | 4.613996e-4 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 4.613996e-4 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 4.635346e-4 |
GO:0060621 | negative regulation of cholesterol import | 4.635346e-4 |
GO:2000381 | negative regulation of mesoderm development | 4.644374e-4 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 4.644374e-4 |
GO:0048286 | lung alveolus development | 4.676211e-4 |
GO:0010656 | negative regulation of muscle cell apoptosis | 4.859547e-4 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 4.971982e-4 |
GO:0072112 | glomerular visceral epithelial cell differentiation | 4.987024e-4 |
GO:0046967 | cytosol to ER transport | 5.071310e-4 |
GO:0019060 | intracellular transport of viral proteins in host cell | 5.071310e-4 |
GO:0010045 | response to nickel ion | 5.071310e-4 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 5.071310e-4 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 5.082821e-4 |
GO:0070303 | negative regulation of stress-activated protein kinase signaling cascade | 5.143045e-4 |
GO:0015937 | coenzyme A biosynthetic process | 5.205554e-4 |
GO:0072166 | posterior mesonephric tubule development | 5.338682e-4 |
GO:0030104 | water homeostasis | 5.353092e-4 |
GO:0032743 | positive regulation of interleukin-2 production | 5.360386e-4 |
GO:0046323 | glucose import | 5.422232e-4 |
GO:0030202 | heparin metabolic process | 5.422232e-4 |
GO:2000426 | negative regulation of apoptotic cell clearance | 5.441535e-4 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 5.441535e-4 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 5.482112e-4 |
GO:0006974 | response to DNA damage stimulus | 5.645709e-4 |
GO:0048641 | regulation of skeletal muscle tissue development | 5.833709e-4 |
GO:0043114 | regulation of vascular permeability | 5.967078e-4 |
GO:0072376 | protein activation cascade | 6.022778e-4 |
GO:0002577 | regulation of antigen processing and presentation | 6.061023e-4 |
GO:0034392 | negative regulation of smooth muscle cell apoptosis | 6.301013e-4 |
GO:0033522 | histone H2A ubiquitination | 6.308652e-4 |
GO:2000242 | negative regulation of reproductive process | 6.452175e-4 |
GO:0060971 | embryonic heart tube left/right pattern formation | 6.789679e-4 |
GO:0006507 | GPI anchor release | 6.789679e-4 |
GO:0034375 | high-density lipoprotein particle remodeling | 7.115828e-4 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 7.285275e-4 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 7.540370e-4 |
GO:0009890 | negative regulation of biosynthetic process | 7.577810e-4 |
GO:0009615 | response to virus | 7.685973e-4 |
GO:0070932 | histone H3 deacetylation | 7.774381e-4 |
GO:0071276 | cellular response to cadmium ion | 8.031484e-4 |
GO:0031935 | regulation of chromatin silencing | 8.224503e-4 |
GO:0060052 | neurofilament cytoskeleton organization | 8.686618e-4 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 8.779717e-4 |
GO:0015696 | ammonium transport | 8.839412e-4 |
GO:0010623 | developmental programmed cell death | 9.026289e-4 |
GO:0072592 | oxygen metabolic process | 9.116137e-4 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 9.606289e-4 |
GO:0045579 | positive regulation of B cell differentiation | 1.004159e-3 |
GO:0006109 | regulation of carbohydrate metabolic process | 1.005435e-3 |
GO:0045921 | positive regulation of exocytosis | 1.010377e-3 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 1.015025e-3 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 1.080340e-3 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 1.082085e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.082085e-3 |
GO:0007356 | thorax and anterior abdomen determination | 1.082085e-3 |
GO:0021587 | cerebellum morphogenesis | 1.090086e-3 |
GO:0060613 | fat pad development | 1.090295e-3 |
GO:0010675 | regulation of cellular carbohydrate metabolic process | 1.097779e-3 |
GO:0051153 | regulation of striated muscle cell differentiation | 1.134039e-3 |
GO:0021697 | cerebellar cortex formation | 1.139432e-3 |
GO:0043306 | positive regulation of mast cell degranulation | 1.152311e-3 |
GO:0051253 | negative regulation of RNA metabolic process | 1.158023e-3 |
GO:0010629 | negative regulation of gene expression | 1.186555e-3 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 1.191868e-3 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.202760e-3 |
GO:2000648 | positive regulation of stem cell proliferation | 1.214328e-3 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 1.239261e-3 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 1.252629e-3 |
GO:2001038 | regulation of cellular response to drug | 1.252629e-3 |
GO:2000685 | positive regulation of cellular response to X-ray | 1.252629e-3 |
GO:0035988 | chondrocyte proliferation | 1.252629e-3 |
GO:0031052 | chromosome breakage | 1.252629e-3 |
GO:0035978 | histone H2A-S139 phosphorylation | 1.252629e-3 |
GO:0003131 | mesodermal-endodermal cell signaling | 1.252629e-3 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.255133e-3 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.272870e-3 |
GO:0010941 | regulation of cell death | 1.322702e-3 |
GO:0033005 | positive regulation of mast cell activation | 1.344192e-3 |
GO:0009164 | nucleoside catabolic process | 1.344192e-3 |
GO:0009116 | nucleoside metabolic process | 1.363140e-3 |
GO:0051126 | negative regulation of actin nucleation | 1.374580e-3 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 1.374580e-3 |
GO:0015693 | magnesium ion transport | 1.413395e-3 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 1.431662e-3 |
GO:0055085 | transmembrane transport | 1.438694e-3 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.483854e-3 |
GO:0010799 | regulation of peptidyl-threonine phosphorylation | 1.503468e-3 |
GO:0045357 | regulation of interferon-beta biosynthetic process | 1.543744e-3 |
GO:0043302 | positive regulation of leukocyte degranulation | 1.574161e-3 |
GO:0048712 | negative regulation of astrocyte differentiation | 1.593047e-3 |
GO:0060969 | negative regulation of gene silencing | 1.624873e-3 |
GO:0060620 | regulation of cholesterol import | 1.624873e-3 |
GO:0045820 | negative regulation of glycolysis | 1.653149e-3 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.675042e-3 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 1.749261e-3 |
GO:0031936 | negative regulation of chromatin silencing | 1.784062e-3 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 1.804746e-3 |
GO:0010159 | specification of organ position | 1.815442e-3 |
GO:0001869 | negative regulation of complement activation, lectin pathway | 1.832104e-3 |
GO:2000020 | positive regulation of male gonad development | 1.834943e-3 |
GO:0061013 | regulation of mRNA catabolic process | 1.848351e-3 |
GO:0070086 | ubiquitin-dependent endocytosis | 1.850981e-3 |
GO:0046638 | positive regulation of alpha-beta T cell differentiation | 1.864488e-3 |
GO:0030513 | positive regulation of BMP signaling pathway | 1.909471e-3 |
GO:0046928 | regulation of neurotransmitter secretion | 1.921620e-3 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 1.928535e-3 |
GO:0046855 | inositol phosphate dephosphorylation | 1.941749e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.941749e-3 |
GO:0070874 | negative regulation of glycogen metabolic process | 2.001763e-3 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 2.011397e-3 |
GO:0006956 | complement activation | 2.044233e-3 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.059819e-3 |
GO:0030573 | bile acid catabolic process | 2.061438e-3 |
GO:0008616 | queuosine biosynthetic process | 2.061438e-3 |
GO:0019882 | antigen processing and presentation | 2.081732e-3 |
GO:0017157 | regulation of exocytosis | 2.097528e-3 |
GO:0032663 | regulation of interleukin-2 production | 2.131645e-3 |
GO:0051932 | synaptic transmission, GABAergic | 2.144317e-3 |
GO:0006683 | galactosylceramide catabolic process | 2.144317e-3 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 2.144317e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 2.155255e-3 |
GO:0005981 | regulation of glycogen catabolic process | 2.257548e-3 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 2.265712e-3 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 2.272009e-3 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 2.272009e-3 |
GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint | 2.272009e-3 |
GO:0019086 | late viral mRNA transcription | 2.272009e-3 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 2.272009e-3 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 2.272009e-3 |
GO:0048009 | insulin-like growth factor receptor signaling pathway | 2.317870e-3 |
GO:0048041 | focal adhesion assembly | 2.336756e-3 |
GO:0006642 | triglyceride mobilization | 2.336756e-3 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 2.344904e-3 |
GO:0070633 | transepithelial transport | 2.363131e-3 |
GO:0070227 | lymphocyte apoptosis | 2.364439e-3 |
GO:0042246 | tissue regeneration | 2.424970e-3 |
GO:0090130 | tissue migration | 2.433452e-3 |
GO:0072362 | regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter | 2.540276e-3 |
GO:0044330 | canonical Wnt receptor signaling pathway involved in positive regulation of wound healing | 2.540276e-3 |
GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter | 2.540276e-3 |
GO:0044329 | canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion | 2.540276e-3 |
GO:0044328 | canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration | 2.540276e-3 |
GO:0021575 | hindbrain morphogenesis | 2.576479e-3 |
GO:0015695 | organic cation transport | 2.589812e-3 |
GO:0032847 | regulation of cellular pH reduction | 2.592300e-3 |
GO:0021707 | cerebellar granule cell differentiation | 2.592300e-3 |
GO:0001780 | neutrophil homeostasis | 2.592300e-3 |
GO:0030644 | cellular chloride ion homeostasis | 2.593073e-3 |
GO:0032667 | regulation of interleukin-23 production | 2.622752e-3 |
GO:0030219 | megakaryocyte differentiation | 2.673081e-3 |
GO:0050918 | positive chemotaxis | 2.688945e-3 |
GO:0043011 | myeloid dendritic cell differentiation | 2.745817e-3 |
GO:0051147 | regulation of muscle cell differentiation | 2.751749e-3 |
GO:0032660 | regulation of interleukin-17 production | 2.801074e-3 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 2.825090e-3 |
GO:0051984 | positive regulation of chromosome segregation | 2.825090e-3 |
GO:0000105 | histidine biosynthetic process | 2.825090e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 2.871762e-3 |
GO:0048050 | post-embryonic eye morphogenesis | 2.882664e-3 |
GO:0080135 | regulation of cellular response to stress | 2.895790e-3 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 2.905747e-3 |
GO:0002830 | positive regulation of type 2 immune response | 2.905747e-3 |
GO:0009125 | nucleoside monophosphate catabolic process | 2.944311e-3 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 2.973322e-3 |
GO:0045767 | regulation of anti-apoptosis | 3.020800e-3 |
GO:0045839 | negative regulation of mitosis | 3.031973e-3 |
GO:0032185 | septin cytoskeleton organization | 3.076605e-3 |
GO:0032497 | detection of lipopolysaccharide | 3.155797e-3 |
GO:0043116 | negative regulation of vascular permeability | 3.177767e-3 |
GO:0070588 | calcium ion transmembrane transport | 3.211706e-3 |
GO:0022415 | viral reproductive process | 3.227056e-3 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 3.274281e-3 |
GO:0042278 | purine nucleoside metabolic process | 3.357122e-3 |
GO:0034220 | ion transmembrane transport | 3.369687e-3 |
GO:0046671 | negative regulation of retinal cell programmed cell death | 3.437793e-3 |
GO:0010633 | negative regulation of epithelial cell migration | 3.437793e-3 |
GO:0006370 | mRNA capping | 3.437793e-3 |
GO:0001570 | vasculogenesis | 3.461904e-3 |
GO:0003097 | renal water transport | 3.476085e-3 |
GO:0043067 | regulation of programmed cell death | 3.561452e-3 |
GO:0010660 | regulation of muscle cell apoptosis | 3.631745e-3 |
GO:0002720 | positive regulation of cytokine production involved in immune response | 3.639254e-3 |
GO:0019748 | secondary metabolic process | 3.647669e-3 |
GO:0010632 | regulation of epithelial cell migration | 3.649585e-3 |
GO:0090181 | regulation of cholesterol metabolic process | 3.649784e-3 |
GO:0021683 | cerebellar granular layer morphogenesis | 3.653417e-3 |
GO:0045686 | negative regulation of glial cell differentiation | 3.703994e-3 |
GO:0015760 | glucose-6-phosphate transport | 3.721699e-3 |
GO:0007264 | small GTPase mediated signal transduction | 3.747438e-3 |
GO:0046069 | cGMP catabolic process | 3.859816e-3 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 3.904731e-3 |
GO:0014904 | myotube cell development | 3.996883e-3 |
GO:0043045 | DNA methylation involved in embryo development | 3.996883e-3 |
GO:0006188 | IMP biosynthetic process | 3.996883e-3 |
GO:0008219 | cell death | 4.069912e-3 |
GO:0070977 | bone maturation | 4.072714e-3 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 4.112453e-3 |
GO:0016090 | prenol metabolic process | 4.150018e-3 |
GO:0042440 | pigment metabolic process | 4.250005e-3 |
GO:0072488 | ammonium transmembrane transport | 4.251993e-3 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 4.333018e-3 |
GO:0030325 | adrenal gland development | 4.354005e-3 |
GO:0030320 | cellular monovalent inorganic anion homeostasis | 4.367395e-3 |
GO:0046502 | uroporphyrinogen III metabolic process | 4.372521e-3 |
GO:0015734 | taurine transport | 4.372521e-3 |
GO:0046148 | pigment biosynthetic process | 4.379163e-3 |
GO:0033151 | V(D)J recombination | 4.379163e-3 |
GO:0010760 | negative regulation of macrophage chemotaxis | 4.538680e-3 |
GO:0001787 | natural killer cell proliferation | 4.538680e-3 |
GO:0071545 | inositol phosphate catabolic process | 4.538749e-3 |
GO:0006189 | 'de novo' IMP biosynthetic process | 4.568094e-3 |
GO:0046831 | regulation of RNA export from nucleus | 4.568094e-3 |
GO:0045046 | protein import into peroxisome membrane | 4.572935e-3 |
GO:0031848 | protection from non-homologous end joining at telomere | 4.572935e-3 |
GO:0016559 | peroxisome fission | 4.572935e-3 |
GO:0006119 | oxidative phosphorylation | 4.594029e-3 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 4.647377e-3 |
GO:0006699 | bile acid biosynthetic process | 4.663345e-3 |
GO:0014916 | regulation of lung blood pressure | 4.679285e-3 |
GO:0072091 | regulation of stem cell proliferation | 4.734113e-3 |
GO:0048332 | mesoderm morphogenesis | 4.902201e-3 |
GO:0006703 | estrogen biosynthetic process | 4.943063e-3 |
GO:0046579 | positive regulation of Ras protein signal transduction | 4.945607e-3 |
GO:0030502 | negative regulation of bone mineralization | 5.043452e-3 |
GO:0060931 | sinoatrial node cell development | 5.070197e-3 |
GO:0003167 | atrioventricular bundle cell differentiation | 5.070197e-3 |
GO:0045738 | negative regulation of DNA repair | 5.126413e-3 |
GO:0050687 | negative regulation of defense response to virus | 5.240932e-3 |
GO:0042981 | regulation of apoptosis | 5.244124e-3 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 5.247704e-3 |
GO:0006310 | DNA recombination | 5.315907e-3 |
GO:0060038 | cardiac muscle cell proliferation | 5.371719e-3 |
GO:0032757 | positive regulation of interleukin-8 production | 5.535283e-3 |
GO:0034983 | peptidyl-lysine deacetylation | 5.583936e-3 |
GO:0016998 | cell wall macromolecule catabolic process | 5.596976e-3 |
GO:0030225 | macrophage differentiation | 5.636223e-3 |
GO:0070295 | renal water absorption | 5.641821e-3 |
GO:0034369 | plasma lipoprotein particle remodeling | 5.672060e-3 |
GO:0045087 | innate immune response | 5.806254e-3 |
GO:0060319 | primitive erythrocyte differentiation | 5.877149e-3 |
GO:0055117 | regulation of cardiac muscle contraction | 5.953644e-3 |
GO:0046329 | negative regulation of JNK cascade | 5.966583e-3 |
GO:0050916 | sensory perception of sweet taste | 6.015402e-3 |
GO:0006713 | glucocorticoid catabolic process | 6.015402e-3 |
GO:0000917 | barrier septum formation | 6.015402e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 6.025560e-3 |
GO:0035802 | adrenal cortex formation | 6.036536e-3 |
GO:0010350 | cellular response to magnesium starvation | 6.036536e-3 |
GO:0046483 | heterocycle metabolic process | 6.050061e-3 |
GO:0060442 | branching involved in prostate gland morphogenesis | 6.167327e-3 |
GO:0071577 | zinc ion transmembrane transport | 6.199133e-3 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 6.251372e-3 |
GO:0060741 | prostate gland stromal morphogenesis | 6.262691e-3 |
GO:0021578 | hindbrain maturation | 6.262691e-3 |
GO:0048755 | branching morphogenesis of a nerve | 6.262691e-3 |
GO:0006784 | heme a biosynthetic process | 6.460239e-3 |
GO:0048619 | embryonic hindgut morphogenesis | 6.485240e-3 |
GO:2000781 | positive regulation of double-strand break repair | 6.535081e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 6.535081e-3 |
GO:0009786 | regulation of asymmetric cell division | 6.535081e-3 |
GO:0031468 | nuclear envelope reassembly | 6.535081e-3 |
GO:0006924 | activation-induced cell death of T cells | 6.558216e-3 |
GO:0006264 | mitochondrial DNA replication | 6.589300e-3 |
GO:0035234 | germ cell programmed cell death | 6.589300e-3 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 6.660501e-3 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 6.700668e-3 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 6.705873e-3 |
GO:0045453 | bone resorption | 6.754588e-3 |
GO:0001894 | tissue homeostasis | 6.794715e-3 |
GO:0007498 | mesoderm development | 6.814227e-3 |
GO:0051973 | positive regulation of telomerase activity | 6.818321e-3 |
GO:0016265 | death | 6.834573e-3 |
GO:2000018 | regulation of male gonad development | 6.869101e-3 |
GO:0009404 | toxin metabolic process | 6.869101e-3 |
GO:0070168 | negative regulation of biomineral tissue development | 6.902216e-3 |
GO:0008595 | anterior/posterior axis specification, embryo | 6.915127e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 6.930515e-3 |
GO:0044272 | sulfur compound biosynthetic process | 6.968838e-3 |
GO:0046487 | glyoxylate metabolic process | 7.055358e-3 |
GO:0019532 | oxalate transport | 7.055358e-3 |
GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain | 7.179040e-3 |
GO:0043508 | negative regulation of JUN kinase activity | 7.248645e-3 |
GO:0070141 | response to UV-A | 7.336070e-3 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 7.336070e-3 |
GO:0055069 | zinc ion homeostasis | 7.378267e-3 |
GO:0007129 | synapsis | 7.378267e-3 |
GO:0048102 | autophagic cell death | 7.379068e-3 |
GO:0033235 | positive regulation of protein sumoylation | 7.416076e-3 |
GO:0070192 | chromosome organization involved in meiosis | 7.453109e-3 |
GO:0001516 | prostaglandin biosynthetic process | 7.453109e-3 |
GO:0050685 | positive regulation of mRNA processing | 7.594981e-3 |
GO:0060463 | lung lobe morphogenesis | 7.874755e-3 |
GO:0043088 | regulation of Cdc42 GTPase activity | 7.874755e-3 |
GO:0021696 | cerebellar cortex morphogenesis | 7.960085e-3 |
GO:0021702 | cerebellar Purkinje cell differentiation | 7.996299e-3 |
GO:0046637 | regulation of alpha-beta T cell differentiation | 8.023655e-3 |
GO:0016202 | regulation of striated muscle tissue development | 8.094004e-3 |
GO:0045404 | positive regulation of interleukin-4 biosynthetic process | 8.134921e-3 |
GO:0019048 | virus-host interaction | 8.193356e-3 |
GO:0002663 | positive regulation of B cell tolerance induction | 8.251104e-3 |
GO:0061198 | fungiform papilla formation | 8.251104e-3 |
GO:0006829 | zinc ion transport | 8.273383e-3 |
GO:0045109 | intermediate filament organization | 8.293829e-3 |
GO:0051057 | positive regulation of small GTPase mediated signal transduction | 8.351210e-3 |
GO:0001935 | endothelial cell proliferation | 8.372342e-3 |
GO:0001732 | formation of translation initiation complex | 8.376728e-3 |
GO:0034330 | cell junction organization | 8.379414e-3 |
GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 8.386851e-3 |
GO:0043931 | ossification involved in bone maturation | 8.457229e-3 |
GO:0006044 | N-acetylglucosamine metabolic process | 8.501323e-3 |
GO:0030500 | regulation of bone mineralization | 8.529842e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 8.628947e-3 |
GO:0006198 | cAMP catabolic process | 8.704832e-3 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 8.705182e-3 |
GO:0055017 | cardiac muscle tissue growth | 8.732483e-3 |
GO:0034655 | nucleobase-containing compound catabolic process | 8.738963e-3 |
GO:0046668 | regulation of retinal cell programmed cell death | 8.814924e-3 |
GO:0014047 | glutamate secretion | 8.814924e-3 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 8.875989e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 8.875989e-3 |
GO:0090104 | pancreatic E cell differentiation | 8.875989e-3 |
GO:0031860 | telomeric 3' overhang formation | 8.875989e-3 |
GO:0003311 | pancreatic D cell differentiation | 8.875989e-3 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 8.875989e-3 |
GO:0010463 | mesenchymal cell proliferation | 9.007656e-3 |
GO:2001020 | regulation of response to DNA damage stimulus | 9.180303e-3 |
GO:0006705 | mineralocorticoid biosynthetic process | 9.208378e-3 |
GO:0048210 | Golgi vesicle fusion to target membrane | 9.284829e-3 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 9.323182e-3 |
GO:0006882 | cellular zinc ion homeostasis | 9.323182e-3 |
GO:2000425 | regulation of apoptotic cell clearance | 9.521716e-3 |
GO:0043691 | reverse cholesterol transport | 9.553040e-3 |
GO:0032026 | response to magnesium ion | 9.590503e-3 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 9.590503e-3 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 9.707260e-3 |
GO:0043154 | negative regulation of caspase activity | 9.719619e-3 |
GO:0046666 | retinal cell programmed cell death | 9.839391e-3 |
GO:0035584 | calcium-mediated signaling using intracellular calcium source | 9.839391e-3 |
GO:0022616 | DNA strand elongation | 9.839391e-3 |
GO:0035356 | cellular triglyceride homeostasis | 9.965229e-3 |
GO:0019464 | glycine decarboxylation via glycine cleavage system | 9.965229e-3 |
GO:0060699 | regulation of endoribonuclease activity | 9.965229e-3 |
GO:0000055 | ribosomal large subunit export from nucleus | 9.965229e-3 |
GO:0000056 | ribosomal small subunit export from nucleus | 9.965229e-3 |
GO:0006348 | chromatin silencing at telomere | 9.965229e-3 |
GO:0045104 | intermediate filament cytoskeleton organization | 9.970450e-3 |
GO:0045815 | positive regulation of gene expression, epigenetic | 9.973742e-3 |
GO:0050778 | positive regulation of immune response | 1.016734e-2 |
GO:0007008 | outer mitochondrial membrane organization | 1.021791e-2 |
GO:0008633 | activation of pro-apoptotic gene products | 1.024693e-2 |
GO:0035404 | histone-serine phosphorylation | 1.045547e-2 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 1.045547e-2 |
GO:0061370 | testosterone biosynthetic process | 1.047157e-2 |
GO:0009648 | photoperiodism | 1.047157e-2 |
GO:0006942 | regulation of striated muscle contraction | 1.048092e-2 |
GO:0042074 | cell migration involved in gastrulation | 1.049682e-2 |
GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 1.054955e-2 |
GO:0045071 | negative regulation of viral genome replication | 1.056481e-2 |
GO:0061044 | negative regulation of vascular wound healing | 1.062836e-2 |
GO:2000098 | negative regulation of smooth muscle cell-matrix adhesion | 1.062836e-2 |
GO:0071258 | cellular response to gravity | 1.062836e-2 |